Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression
Open Access
- 1 January 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 290 (1), E42-E46
- https://doi.org/10.1152/ajpendo.00240.2005
Abstract
Plasma levels of adiponectin are lower in obese and insulin-resistant subjects compared with lean and insulin-sensitive ones. Thiazolidinediones increase plasma adiponectin levels in diabetic subjects, although the mechanism of this increased plasma adiponectin has not been well studied. In the present study, we compared the plasma levels and adipose tissue expression of adiponectin in subjects with normal (NGT) and impaired glucose tolerance (IGT) and also studied the effects of metformin and pioglitazone on plasma and adipose tissue mRNA level of adiponectin in IGT subjects. IGT subjects had lower plasma adiponectin levels compared with NGT subjects, and similarly IGT subjects had lower adiponectin mRNA levels. In contrast, the increased plasma levels of adiponectin in response to pioglitazone were not associated with increased adiponectin expression in adipose tissue. Metformin did not cause any change in plasma or expression levels of adiponectin. Other adipokines were examined, and both pioglitazone and metformin decreased plasma levels of resistin in IGT subjects, and pioglitazone (but not metformin) decreased plasma levels of leptin. These data suggest that pioglitazone increases plasma adiponectin levels by posttranscriptional regulation in contrast to transcriptional regulation of adiponectin in relation to insulin sensitivity in NGT vs. IGT subjects.Keywords
This publication has 39 references indexed in Scilit:
- Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndromeJournal of Internal Medicine, 2005
- Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patientsInternational Journal of Obesity, 2004
- Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin SensitivityJournal of Biological Chemistry, 2004
- Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 DiabetesNew England Journal of Medicine, 2004
- Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/AdiponectinPublished by Elsevier BV ,2003
- Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic PatientsJournal of Clinical Endocrinology & Metabolism, 2002
- Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPAR Agonists: A Potential Mechanism of Insulin SensitizationEndocrinology, 2002
- Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic PatientsDiabetes Care, 2002
- Identification and Adipocyte Differentiation-dependent Expression of the Unique Disialic Acid Residue in an Adipose Tissue-specific Glycoprotein, Adipo QPublished by Elsevier BV ,2001
- Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.JCI Insight, 1987